Extracorporeal magnetotransduction therapy as an adjunctive and primary modality for bone healing: a scoping review of current evidence

Preliminary evidence supports EMTT as a safe and potentially viable non-operative modality, primarily as an adjunct to established treatments such as ESWT. These studies also illustrate EMTT's potential to enhance angiogenesis, osteogenic gene expression, and clinical bone healing. Clinical cases of delayed union and non-union fractures demonstrating healing with EMTT, resulting in successful union and return to sport for all patients reported. While results suggest synergistic effects with Extracorporeal Shockwave Therapy (ESWT), the evidence remains limited by small sample sizes, publication bias, and confounding adjunct therapies. Future randomized controlled trials are required to establish standardized protocols and isolate EMTT's efficacy as monotherapy.